• 8577 Citations
  • 34 h-Index
1965 …2017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Henry Wagner Jr. is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Radiotherapy Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Thorax Medicine & Life Sciences
Radiation Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1997 2009


Wagner Jr., H., Kish, J., Fernandez, H. & Sondak, V. K.

National Institutes of Health


Project: Research project

Organized Financing
Veterans Hospitals
United States Department of Veterans Affairs
General Hospitals

Research Output 1965 2017

40 Citations (Scopus)

Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone

Koller, K. M., Mackley, H., Liu, J., Wagner Jr., H., Talamo, G., Schell, T., Pameijer, C. R., Neves, R., Anderson, B., Kokolus, K. M., Mallon, C. A. & Drabick, J., Jan 2 2017, In : Cancer Biology and Therapy. 18, 1, p. 36-42 7 p.

Research output: Contribution to journalReview article

Drug Therapy
12 Citations (Scopus)

A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402

Witzig, T. E., Hong, F., Micallef, I. N., Gascoyne, R. D., Dogan, A., Wagner Jr., H., Kahl, B. S., Advani, R. H. & Horning, S. J., Jan 1 2015, In : British Journal of Haematology. 170, 5, p. 679-686 8 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Non-Hodgkin's Lymphoma
15 Citations (Scopus)

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era

Diefenbach, C. S., Li, H., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Crump, M., Gascoyne, R. D., Wagner Jr., H., Stiff, P. J., Cheson, B. D., Stewart, D. A., Kahl, B. S., Friedberg, J. W., Blum, K. A., Habermann, T. M., Tuscano, J. M., Hoppe, R. T., Horning, S. J. & Advani, R. H., Nov 1 2015, In : British Journal of Haematology. 171, 4, p. 530-538 9 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Age Factors
Proportional Hazards Models
7 Citations (Scopus)

Optimal frequency of psychosocial distress screening in radiation oncology

Hess, C. B., Singer, M., Khaku, A., Malinou, J., Juliano, J. J., Varlotto, J. M., Wagner Jr., H., Liao, J. J., Myers, K., Levine, M. & Mackley, H., Jul 1 2015, In : Journal of oncology practice. 11, 4, p. 298-302 5 p.

Research output: Contribution to journalArticle

Radiation Oncology